Crescent Sterling Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$1.5M |
| 2 |
ExxonMobil
XOM
|
+$758K |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
+$533K |
| 4 |
Johnson & Johnson
JNJ
|
+$473K |
| 5 |
Lowe's Companies
LOW
|
+$464K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Norfolk Southern
NSC
|
+$805K |
| 2 |
CCRN
Cross Country Healthcare
CCRN
|
+$246K |
| 3 |
Schwab US Mid-Cap ETF
SCHM
|
+$239K |
| 4 |
Eli Lilly
LLY
|
+$206K |
| 5 |
Microsoft
MSFT
|
+$159K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.31% |
| 2 | Healthcare | 17.36% |
| 3 | Consumer Staples | 12.46% |
| 4 | Energy | 11.5% |
| 5 | Materials | 6.31% |
Similar funds
Crescent Sterling's Q1 2023 Portfolio in Review
As of Q1 2023, Crescent Sterling held 77 positions worth $103M, up 10% from $93.2M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Crescent Sterling deployed $9.15M of net new capital in Q1 2023, opening 11 new positions and adding to 56 existing holdings. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 3,210 shares worth $1.47M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Schwab US Mid-Cap ETF, an estimated $239K trimmed.
- Crescent Sterling's largest Q1 2023 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 3,210 shares worth $1.47M.
- Crescent Sterling added most to ExxonMobil in Q1 2023, an estimated $758K increase.
- Crescent Sterling's biggest Q1 2023 reduction was Schwab US Mid-Cap ETF, cutting an estimated $239K.
- Crescent Sterling fully exited Norfolk Southern in Q1 2023, selling an estimated $805K.
- Crescent Sterling's ten largest holdings make up 42% of its $103M portfolio in Q1 2023.
- Crescent Sterling opened 11 new positions and closed 3 in Q1 2023.
- Crescent Sterling's portfolio value rose 10% quarter-over-quarter to $103M.
Based on Crescent Sterling's 13F filing for Q1 2023, filed 21 Apr 2023.